Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 153-163, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (71)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bry, L.
Right arrow Articles by Sacks, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bry, L.
Right arrow Articles by Sacks, D. B.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2001;47:153-163.)
© 2001 American Association for Clinical Chemistry, Inc.


Reviews

Effects of Hemoglobin Variants and Chemically Modified Derivatives on Assays for Glycohemoglobin

Lynn Bry1, Philip C. Chen1 and David B. Sacksa,1

1 Department of Pathology, Brigham & Women’s Hospital, Harvard Medical School, 75 Francis St., Boston, MA 02115.
a Address correspondence to this author at: Brigham & Women’s Hospital, Thorn 530, 75 Francis St., Boston, MA 02115. E-mail dsacks{at}rics.bwh.harvard.edu.

Background: Glycohemoglobin (gHb), measured as hemoglobin (Hb) A1c or as total gHb, provides a common means for assessing long-term glycemic control in individuals with diabetes mellitus. Genetic variants and chemically modified derivatives of Hb can profoundly affect the accuracy of these measurements, although effects vary considerably among commercially available methods. The prevalence of genetic variants such as HbS, HbC, and HbE, and chemically modified derivatives such as carbamyl-Hb among patient populations undergoing testing is not insignificant. Clinical laboratories and sites responsible for point-of-care testing of gHb need to be aware of the interferences produced in assays by these Hbs.

Approach: We conducted a review of the literature describing the effects of variant Hbs on gHb assay methods commonly used in clinical laboratories.

Content: This review summarizes the documented effects of both common and uncommon Hb variants and derivatives on the measurement of gHb. Where known, we discuss mechanisms of interference on specific assays and methodologies. We specifically address effects of commonly encountered Hbs, such as carbamyl-Hb, HbS, HbC, HbE, and HbF, on assays that use cation-exchange chromatography, immunoassays, or boronate affinity methods for measuring gHb.

Summary: A variety of patient- and laboratory-related factors can adversely affect the measurement of gHb in patients harboring Hb variants or derivatives. Identification of the variant or derivative Hb before or during testing may allow accurate measurement of gHb by the selection of a method unaffected by the given variant or derivative. However, laboratories should make available alternative, non-Hb-based methods for assessing long-term glycemic control in individuals with HbCC, HbSS, or HbSC disease, or with other underlying disorders where the concentration of gHb does not accurately reflect long-term glycemic control.




The following articles in journals at HighWire Press have cited this article:


Home page
J. Clin. Endocrinol. Metab.Home page
C. D. Saudek, W. H. Herman, D. B. Sacks, R. M. Bergenstal, D. Edelman, and M. B. Davidson
A New Look at Screening and Diagnosing Diabetes Mellitus
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2447 - 2453.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Fukui, M. Tanaka, G. Hasegawa, T. Yoshikawa, and N. Nakamura
Association Between Serum Bioavailable Testosterone Concentration and the Ratio of Glycated Albumin to Glycated Hemoglobin in Men With Type 2 Diabetes
Diabetes Care, March 1, 2008; 31(3): 397 - 401.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
J. M. Abadie and A. A. Koelsch
Performance of the Roche Second Generation Hemoglobin A1c Immunoassay in the Presence of Hb-S or Hb-C Traits
Ann. Clin. Lab. Sci., January 1, 2008; 38(1): 31 - 36.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
A. Smaldone
Glycemic Control and Hemoglobinopathy: When A1C May Not Be Reliable
Diabetes Spectr, January 1, 2008; 21(1): 46 - 49.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
S.-T. Lee, C. W. Weykamp, Y.-W. Lee, J.-W. Kim, and C.-S. Ki
Effects of 7 Hemoglobin Variants on the Measurement of Glycohemoglobin by 14 Analytical Methods
Clin. Chem., December 1, 2007; 53(12): 2202 - 2205.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Y. Wang, B. Beckwith, C. Smith, and G. Horowitz
Misleading Glycated Hemoglobin Results in a Patient with Hemoglobin SC Disease
Clin. Chem., July 1, 2007; 53(7): 1394 - 1395.
[Full Text] [PDF]


Home page
Clin. DiabetesHome page
R. J. Schrot, K. T. Patel, and P. Foulis
Evaluation of Inaccuracies in the Measurement of Glycemia in the Laboratory, by Glucose Meters, and Through Measurement of Hemoglobin A1c
Clin. Diabetes, April 1, 2007; 25(2): 43 - 49.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. L. Roberts
Hemoglobin Constant Spring Can Interfere with Glycated Hemoglobin Measurements by Boronate Affinity Chromatography
Clin. Chem., January 1, 2007; 53(1): 142 - 143.
[Full Text] [PDF]


Home page
Diabetes CareHome page
J. K. Kirk, R. B. D'Agostino Jr., R. A. Bell, L. V. Passmore, D. E. Bonds, A. J. Karter, and K.M. V. Narayan
Disparities in HbA1c Levels Between African-American and Non-Hispanic White Adults With Diabetes: A meta-analysis.
Diabetes Care, September 1, 2006; 29(9): 2130 - 2136.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S.-T. Lee, M. S. Kim, D. Y. Choi, S. K. Kim, and C.-S. Ki
Incidence of variant hemoglobin (hb) and increased fetal hb concentrations and their effect on hb a1c measurement in a korean population.
Clin. Chem., July 1, 2006; 52(7): 1445 - 1446.
[Full Text] [PDF]


Home page
Diabetes CareHome page
C. B. Hart
Race Differences in Long-Term Diabetes Management in an HMO: Response to Adams et al.
Diabetes Care, June 1, 2006; 29(6): 1461 - 1462.
[Full Text] [PDF]


Home page
JAMAHome page
C. D. Saudek, R. L. Derr, and R. R. Kalyani
Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1c
JAMA, April 12, 2006; 295(14): 1688 - 1697.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. Ostendorf, T. Glosemeyer-Allhoff, K. Schauerte, and R. Yamamoto
Hemoglobin (Hb) Stanleyville II Causes Gross Overestimation of the Hb A1c Proportion in Routine HPLC
Clin. Chem., September 1, 2005; 51(9): 1752 - 1754.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Zurbriggen, M. Schmugge, M. Schmid, S. Durka, P. Kleinert, T. Kuster, C. W. Heizmann, and H. Troxler
Analysis of Minor Hemoglobins by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
Clin. Chem., June 1, 2005; 51(6): 989 - 996.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. L. Roberts, S. Safar-Pour, B. K. De, C. L. Rohlfing, C. W. Weykamp, and R. R. Little
Effects of Hemoglobin C and S Traits on Glycohemoglobin Measurements by Eleven Methods
Clin. Chem., April 1, 2005; 51(4): 776 - 778.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
R. R. Little, H. Vesper, C. L. Rohlfing, M. Ospina, S. Safar-Pour, and W. L. Roberts
Validation by a Mass Spectrometric Reference Method of Use of Boronate Affinity Chromatography to Measure Glycohemoglobin in the Presence of Hemoglobin S and C Traits
Clin. Chem., January 1, 2005; 51(1): 264 - 265.
[Full Text] [PDF]


Home page
Diabetes CareHome page
A. Chico, A. Padros, and A. Novials
The Korle-Bu Hb Variant in Caucasian Women With Type 1 Diabetes: A pitfall in the assessment of diabetes control
Diabetes Care, September 1, 2004; 27(9): 2280 - 2281.
[Full Text] [PDF]


Home page
Diabetes CareHome page
D. E. Goldstein, R. R. Little, R. A. Lorenz, J. I. Malone, D. Nathan, C. M. Peterson, and D. B. Sacks
Tests of Glycemia in Diabetes
Diabetes Care, July 1, 2004; 27(7): 1761 - 1773.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
B. L Armor and M. L Britton
Diabetes Mellitus Non-Glucose Monitoring: Point-of-Care Testing
Ann. Pharmacother., June 1, 2004; 38(6): 1039 - 1047.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
J L Camargo and J L Gross
Conditions associated with very low values of glycohaemoglobin measured by an HPLC method
J. Clin. Pathol., April 1, 2004; 57(4): 346 - 349.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. B. Sacks
Hemoglobin Variants and Hemoglobin A1c Analysis: Problem Solved?
Clin. Chem., August 1, 2003; 49(8): 1245 - 1247.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
C M Florkowski, T A Walmsley, S O Brennan, and P M George
Haemoglobin Marseille-Long Island and interpretation of HbA1c: which HbA1c result is the "right answer"?
Postgrad. Med. J., March 1, 2003; 79(929): 174 - 175.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. M. Cohen, Y. R. Holmes, T. C. Chenier, and C. H. Joiner
Discordance Between HbA1c and Fructosamine: Evidence for a glycosylation gap and its relation to diabetic nephropathy
Diabetes Care, January 1, 2003; 26(1): 163 - 167.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. Bisse, C. Schauber, N. Zorn, T. Epting, A. Eigel, A. Van Dorsselaer, H. Wieland, J. Kister, and L. Kiger
Hemoglobin Gorwihl [{alpha}2{beta}25(A2)Pro->Ala], an Electrophoretically Silent Variant with Impaired Glycation
Clin. Chem., January 1, 2003; 49(1): 137 - 143.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
T Lahousen, R E Roller, R W Lipp, and W J Schnedl
Silent haemoglobin variants and determination of HbA1c with the HPLC Bio-Rad Variant II
J. Clin. Pathol., September 1, 2002; 55(9): 699 - 703.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. B. Sacks, D. E. Bruns, D. E. Goldstein, N. K. Maclaren, J. M. McDonald, and M. Parrott
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
Clin. Chem., March 1, 2002; 48(3): 436 - 472.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. L. Roberts, B. K. De, D. Brown, C. M. Hanbury, J. D. Hoyer, W. G. John, T. L. Lambert, R. B. Lundell, C. Rohlfing, and R. R. Little
Effects of Hemoglobin C and S Traits on Eight Glycohemoglobin Methods
Clin. Chem., February 1, 2002; 48(2): 383 - 385.
[Full Text] [PDF]

eLetters:

Read all eLetters

Incorrect Reference
Trefor Higgins, et al.
Clinical Chemistry Online, 15 Mar 2001 [Full text]
HbA1c Determination In Patients With Uncommon Hb Variants
Wolfgang Schnedl, et al.
Clinical Chemistry Online, 16 Apr 2001 [Full text]
rebuttal
lynn bry, et al.
Clinical Chemistry Online, 8 May 2001 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.